CPhI grades Japan in the second position for Pharma

Industry supervisors envisage Japan to be the second fastest growing mature marketplace for solid dose drugs in 2019 followed by the United States. The findings represent a considerable year-on-year improvement in outlook for pharma in Japan with expected growth of solid dose formulations improving by more than 10% with generic drug classes highlighted Significantly, it ranks ahead of all EU nations and Korea. The report concludes that Japan is a ripened country for growth across a number of product classes, but the enduring winners of regulatory changes and innovative R&D remain hard to pick.

Reference Link: https://biospectrumasia.com/news/50/12865/japan-second-fastest-pharma-growth-in-2019-cphi-report.html


You may also like

0 thoughts on “CPhI grades Japan in the second position for Pharma”

LEAVE A REPLY

Your email address will not be published. Required fields are marked *

  • MOST READ
  • MOST RECENT

Publication Cycle: An Overview

By Manuscriptedit - Jul 28,2017

Does Journal Acceptance Rates Matter?

By Manuscriptedit - Aug 04,2017

Bibliometric/Scientometric Indicators

By Manuscriptedit - Jun 19,2017

How to use the full stop ?

By Manuscriptedit - Sep 28, 2009

How to use the question mark ?

By Manuscriptedit - Sep 28, 2009

How to use the exclamation mark ?

By Manuscriptedit - Sep 28, 2009

How to use the comma ?

By Manuscriptedit - Sep 28, 2009

Tips